NCT00291187View on ClinicalTrials.gov

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

PHASE3CompletedINTERVENTIONAL
Enrollment

411

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Insomnia
Interventions
DRUG

20 mg VEC-162

20 mg VEC-162

DRUG

50 mg VEC-162

50 mg VEC-162

DRUG

100 mg VEC-162

100 mg VEC-162

DRUG

Placebo

Placebo

Trial Locations (19)

Unknown

Vanda Investigational Site, Birmingham

Vanda Investigational Site, Phoenix

Vanda Investigational Site, San Diego

Vanda Investigational Site, San Francisco

Vanda Investigational Site, Santa Monica

Vanda Investigational Site, Miami

Vanda Investigational Site, Naples

Vanda Investigational Site, Pembroke Pines

Vanda Investigational Site, St. Petersburg

Vanda Investigational Site, Atlanta

Vanda Investigational Site, Overland Park

Vanda Investigational Site, Chevy Chase

Vanda Investigational Site, New York

Vanda Investigational Site, Rochester

Vanda Investigational Site, Raleigh

Vanda Investigational Site, Cincinnati

Vanda Investigational Site, Columbia

Vanda Investigational Site, Austin

Vanda Investigational Site, Plano

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY